Evaluation and predictive factors analyses for patient-self-reported depression, anxiety and quality of life in patients with metastatic renal cell carcinoma underwent interferon-α treatment: a prospective cohort study

Background: null This study aimed to investigate the patient-self-reported depression, anxiety and quality of life (QoL) as well as their predictive factors in patients with metastatic renal cell carcinoma (mRCC) underwent interferon-alpha (IFN-α) treatment. Methods: null A total of 127 patients with mRCC underwent IFN-α treatment were consecutively enrolled in this prospective cohort study. Anxiety, depression and QoL were assessed at week 0...